Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Syneos Health Inc (SYNH)

Syneos Health Inc (SYNH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,763,791
  • Shares Outstanding, K 103,796
  • Annual Sales, $ 4,390 M
  • Annual Income, $ 24,280 K
  • 60-Month Beta 1.50
  • Price/Sales 1.28
  • Price/Cash Flow 10.20
  • Price/Book 1.96

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.89
  • Number of Estimates 5
  • High Estimate 0.91
  • Low Estimate 0.87
  • Prior Year 0.89
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.35 +17.28%
on 11/08/19
55.68 -0.27%
on 12/06/19
+7.29 (+15.11%)
since 11/06/19
3-Month
47.35 +17.28%
on 11/08/19
55.90 -0.66%
on 10/16/19
+2.44 (+4.60%)
since 09/06/19
52-Week
36.26 +53.12%
on 12/24/18
56.34 -1.44%
on 02/25/19
+6.32 (+12.84%)
since 12/06/18

Most Recent Stories

More News
SYNH vs. HMSY: Which Stock Should Value Investors Buy Now?

SYNH vs. HMSY: Which Stock Is the Better Value Option?

SYNH : 55.53 (+2.51%)
HMSY : 29.50 (+0.99%)
Syneos Health Releases Report Identifying Barriers to Payer Use of RWE in Rare Disease and Recommendations for Advancing Payer Engagement

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released "Real World Value: Advancing Payer Understanding of RWE in Rare Disease," a report identifying...

SYNH : 55.53 (+2.51%)
Is Syneos Health (SYNH) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

SYNH : 55.53 (+2.51%)
Syneos Health Collaborates with AiCure for Patient Engagement

Syneos Health (SYNH) aims to optimize patient engagement and trial success by partnering with AiCure.

HAE : 121.26 (+1.22%)
NUVA : 74.75 (+1.33%)
GWPH : 101.05 (-2.39%)
SYNH : 55.53 (+2.51%)
Syneos Health to Present at the Jefferies 2019 London Healthcare Conference

Syneos Health(R) (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced...

SYNH : 55.53 (+2.51%)
Bernadette Connaughton Appointed to Syneos Health Board of Directors

Syneos Health (Nasdaq:SYNH), a leading biopharmaceutical solutions organization combining a Contract Research Organization (CRO) and a Contract Commercial Organization (CCO), today announced the appointment...

ZEAL : 32.87 (+5.83%)
HALO : 19.16 (+0.52%)
SYNH : 55.53 (+2.51%)
Syneos Health and AiCure Announce Partnership to Optimize Patient Engagement and Trial Success

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and AiCure, an AI and advanced data analytics company, today announced a novel strategic partnership to...

SYNH : 55.53 (+2.51%)
SYNH vs. OMCL: Which Stock Should Value Investors Buy Now?

SYNH vs. OMCL: Which Stock Is the Better Value Option?

SYNH : 55.53 (+2.51%)
OMCL : 81.52 (+1.44%)
Syneos Health (SYNH) Tops Q3 Earnings Estimates, Ups EPS View

Syneos Health (SYNH) exhibits robust topline performance in the third quarter, backed by strong segmental growth.

TMO : 320.12 (+1.30%)
NUVA : 74.75 (+1.33%)
RMD : 150.59 (+0.27%)
SYNH : 55.53 (+2.51%)
Syneos Health (SYNH) Surpasses Q3 Earnings Estimates

Syneos Health (SYNH) delivered earnings and revenue surprises of 4.82% and -0.44%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

SYNH : 55.53 (+2.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade SYNH with:

Business Summary

Syneos Health Inc. is an integrated biopharmaceutical solutions organization. It includes a Contract Research Organization and Contract Commercial Organization to accelerate customer performance to address modern market realities. Syneos Health Inc., formerly known as INC Research Holdings Inc., is based...

See More

Key Turning Points

2nd Resistance Point 56.39
1st Resistance Point 55.96
Last Price 55.53
1st Support Level 54.82
2nd Support Level 54.12

See More

52-Week High 56.34
Last Price 55.53
Fibonacci 61.8% 48.67
Fibonacci 50% 46.30
Fibonacci 38.2% 43.93
52-Week Low 36.26

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar